As global leaders gather for Unstoppable Africa 2026, Roche has reaffirmed its commitment to advancing healthcare as a primary driver of economic resilience across the continent through the Africa Breast Cancer Ambition (ABCA). Roche states that the program collaborates with local communities, multilateral institutions, and governments to build the systemic frameworks necessary for a five-year … Read more
A new regression-based prognostic model developed by researchers at the University of North Carolina uses routine electronic health record data to estimate near-term death risks for patients with metastatic breast cancer, according to findings published in JCO Oncology Practice. Led by Dr. Emily Ray, the tool aims to help oncologists recognize high-risk periods and prompt … Read more
Researchers at Ludwig Princeton have discovered that tumors can manipulate distant organs to evade the immune system, according to a study published in Cell Metabolism. Led by Yibin Kang and Yong Tang, the research demonstrates how cancer cells send signals across the body to alter fat metabolism in the liver and immune responses in CD8⁺ … Read more
According to research published in EMBO Molecular Medicine by teams at Adelaide University and the Olivia Newton-John Cancer Research Institute, a molecular switch driven by low levels of the naturally occurring molecule miR-342 and high activity of the E2F pathway fosters metastatic triple-negative breast cancer. While this aggressive subtype accounts for 10 to 15 percent … Read more
According to research published in the Chinese Medical Journal, a mitochondrial matrix protein known as RTN4IP1 drives the progression and metastasis of triple-negative breast cancer by disrupting cellular energy metabolism. Triple-negative breast cancer accounts for roughly 15% of all breast cases and lacks estrogen, progesterone, and HER2 receptors, leaving patients with high risks of recurrence … Read more
Astrin Biosciences is expanding physician outreach and preparing a direct-to-consumer launch for Certitude, a proteomic-based breast cancer diagnostic test that leverages mass spectrometry and machine learning. According to the company, the test identifies high-risk patients and detects early-stage malignancies from a small plasma sample. How Proteomics and AI Outperform Traditional DNA Liquid Biopsies in Early … Read more
< div> According to peer-reviewed research published in July in Cancer Research, sildenafil—the active ingredient in Viagra—disrupts cancer cells’ cholesterol supply to stop the spread of metastases. Researchers at the Weizmann Institute of Science, alongside teams from the US National Cancer Institute and Clalit Health Services, found that the drug targets the protein transporting essential … Read more
According to medical experts, lifestyle interventions such as diet modifications, stress reduction, and natural remedies cannot cure cancer or replace evidence-based treatments like chemotherapy and surgery. While healthy habits support patient well-being, oncologists warn that delaying proven medical care to pursue alternative therapies allows the disease to progress and reduces survival chances. The Limits of … Read more
Cardiovascular risk calculators currently used by doctors to predict heart attacks and strokes can also estimate a patient’s risk of developing certain cancers, according to a study published in the European Journal of Cancer. Researchers at University College London (UCL) found that tools like QRISK3—widely used in the UK—performed with comparable accuracy to specialized cancer … Read more
Research from the University of Virginia (UVA) Comprehensive Cancer Center indicates that a buildup of bile acids, triggered by an unhealthy gut microbiome, can drive hormone receptor-positive (HR+) breast cancer to metastasize to other organs, particularly the lungs. According to Melanie Rutkowski, PhD, this mechanism suggests that FDA-approved bile acid sequestrants or microbiome replenishment could … Read more